Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Fallopian Tube Cancer - Pipeline Review, H2 2017 - Research and Markets

Research and Markets
Posted on: 20 Dec 17

The "Fallopian Tube Cancer - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Fallopian Tube Cancer - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Fallopian Tube Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Fallopian Tube Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Fallopian Tube Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 2, 13, 59, 37, 13, 1 and 1 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 6 and 2 molecules, respectively.

Fallopian Tube Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Fallopian Tube Cancer - Overview
  3. Fallopian Tube Cancer - Therapeutics Development
  4. Fallopian Tube Cancer - Therapeutics Assessment
  5. Fallopian Tube Cancer - Companies Involved in Therapeutics Development
  6. Fallopian Tube Cancer - Drug Profiles
  7. Fallopian Tube Cancer - Dormant Projects
  8. Fallopian Tube Cancer - Discontinued Products
  9. Fallopian Tube Cancer - Product Development Milestones
  10. Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 20/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.